Abstract
Purpose
Significant malnutrition exists in a high percentage of patients with gastric cancer. It is, therefore, crucial to establish an effective means to provide nutrition for these patients. This prospective, randomized, double-blinded clinical trial aims to assess the long-term survival of arginine-supplementation enteral nutrition versus standard enteral nutrition in malnourished patients with gastric cancer.
Methods
The control group (36 cases) received postoperative standard enteral nutrition. Meanwhile, the arginine-supplementation group (37 cases) adopted the same nutrition product but enriched with arginine (9.0 g/L). The primary study objective was overall survival (OS). Secondary endpoints were progression-free survival (PFS); serum parameters including total protein, albumin, proalbumin, and transferrin obtained on preoperative day 1, postoperative day 2, and day 12; CD4+ and CD8+ T cells, natural killer (NK) cells, immunoglobulin M (IgM), and immunoglobulin G (IgG) obtained on preoperative day 1 and postoperative day 7.
Results
No significant differences in baseline characteristics were observed between groups. The group receiving arginine-enriched nutrition had a significantly better OS (P = 0.03, 41 vs. 30.5 months) and better PFS (P = 0.02, 18 vs. 11.5 months). On postoperative day 7, CD4+ T cells, NK cells, IgM and IgG levels of the arginine-supplemented group increased prominently and were significantly higher than those of the control group and those on preoperative day 1. There is no significant difference in the serum total protein, albumin, proalbumin, and transferrin levels between the two arms.
Conclusions
Arginine-supplemented enteral nutrition significantly improves long-term survival and restores immunity in malnourished gastric cancer.
Similar content being viewed by others
References
Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB (1995) Relaxin activates the l-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 55(22):5272–5275
Bosetti C, Bertuccio P, Levi F, Lucchini F, Negri E, La Vecchia C (2008) Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis. Ann Oncol 19(4):631–640. doi:10.1093/annonc/mdm597mdm597
Buijs N, van Bokhorst-de van der Schueren MA, Langius JA, Leemans CR, Kuik DJ, Vermeulen MA, van Leeuwen PA (2010) Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. Am J Clin Nutr 92(5):1151–1156. doi:10.3945/ajcn.2010.29532ajcn.2010.29532
Chen DW, Wei Fei Z, Zhang YC, Ou JM, Xu J (2005) Role of enteral immunonutrition in patients with gastric carcinoma undergoing major surgery. Asian J Surg 28(2):121–124
Dimmeler S, Haendeler J, Nehls M, Zeiher AM (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185(4):601–607
Gianotti L, Braga M, Fortis C, Soldini L, Vignali A, Colombo S, Radaelli G, Di Carlo V (1999) A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. JPEN J Parenter Enteral Nutr 23(6):314–320
Gil-Rendo A, Hernandez-Lizoain JL, Martinez-Regueira F, Sierra Martinez A, Rotellar Sastre F, Cervera Delgado M, Valenti Azcarate V, Pastor Idoate C, Alvarez-Cienfuegos J (2006) Risk factors related to operative morbidity in patients undergoing gastrectomy for gastric cancer. Clin Transl Oncol 8(5):354–361
Griffiths RD, Bongers T (2005) Nutrition support for patients in the intensive care unit. Postgrad Med J 81(960):629–636. doi:10.1136/pgmj.2005.033399
Kelley JR, Duggan JM (2003) Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56(1):1–9
Lin MT, Saito H, Fukushima R, Inaba T, Fukatsu K, Inoue T, Furukawa S, Han I, Muto T (1996) Route of nutritional supply influences local, systemic, and remote organ responses to intraperitoneal bacterial challenge. Ann Surg 223(1):84–93
Lind DS (2004) Arginine and cancer. J Nutr 134 (10 Suppl):2837S–2841S (discussion 2853S)
Liu H, Ling W, Shen ZY, Jin X, Cao H (2012) Clinical application of immune-enhanced enteral nutrition in patients with advanced gastric cancer after total gastrectomy. J Dig Dis 13(8):401–406. doi:10.1111/j.1751-2980.2012.00596.x
Meguid MM, Debonis D, Meguid V, Hill LR, Terz JJ (1988) Complications of abdominal operations for malignant disease. Am J Surg 156(5):341–345
Merimee TJ, Rabinowtitz D, Fineberg SE (1969) Arginine-initiated release of human growth hormone. Factors modifying the response in normal man. N Engl J Med 280(26):1434–1438. doi:10.1056/NEJM196906262802603
Messmer UK, Ankarcrona M, Nicotera P, Brune B (1994) p53 expression in nitric oxide-induced apoptosis. FEBS Lett 355(1):23–26
Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB, Kellum JM Jr, Welling RE, Moore EE (1992) Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 216(2):172–183
Nicotera P, Bonfoco E, Brune B (1995) Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimmunol 5(4):411–420
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74–108
Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR (1998) Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 82(4):621–631
Senkal M, Zumtobel V, Bauer KH, Marpe B, Wolfram G, Frei A, Eickhoff U, Kemen M (1999) Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 134(12):1309–1316
Stechmiller JK, Childress B, Porter T (2004) Arginine immunonutrition in critically ill patients: a clinical dilemma. Am J Crit Care 13(1):17–23
Sungurtekin H, Sungurtekin U, Balci C, Zencir M, Erdem E (2004) The influence of nutritional status on complications after major intraabdominal surgery. J Am Coll Nutr 23(3):227–232
van Bokhorst-De Van Der Schueren MA, Quak JJ, von Blomberg-van der Flier BM, Kuik DJ, Langendoen SI, Snow GB, Green CJ, van Leeuwen PA (2001) Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr 73(2):323–332
Vissers YL, Dejong CH, Luiking YC, Fearon KC, von Meyenfeldt MF, Deutz NE (2005) Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency? Am J Clin Nutr 81(5):1142–1146
Weimann A, Braga M, Harsanyi L, Laviano A, Ljungqvist O, Soeters P, Jauch KW, Kemen M, Hiesmayr JM, Horbach T, Kuse ER, Vestweber KH (2006) ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 25(2):224–244. doi:10.1016/j.clnu.2006.01.015
Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12(1):17–20
Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O’Neill A, Mier J, Ochoa AC (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 65(8):3044–3048. doi:10.1158/0008-5472.CAN-04-4505
Zheng Y, Li F, Qi B, Luo B, Sun H, Liu S, Wu X (2007) Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr 16(Suppl 1):253–257
Conflict of interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00432-015-1913-6.
Our paper entitled “Randomized clinical trial of arginine-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery” reported that arginine-supplemented enteral nutrition significantly improved long-term survival and restored immunity in malnourished gastric cancer. However, recently we checked our data again and found there was an obvious difference between experimental and control groups in the tumor status at the beginning of the trial. In addition, the sample size was not calculated, which might be not enough to reach a significant power. Thus, the trial might be biased and we, the authors, believe that the most responsible course of action is to retract our paper. We deeply regret this circumstance and apologize to the community.
A comment to this article is available at http://dx.doi.org/10.1007/s00432-014-1608-4.
A comment to this article is available at http://dx.doi.org/10.1007/s00432-014-1609-3.
About this article
Cite this article
Zhao, H., Zhao, H., Wang, Y. et al. RETRACTED ARTICLE: Randomized clinical trial of arginine-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery. J Cancer Res Clin Oncol 139, 1465–1470 (2013). https://doi.org/10.1007/s00432-013-1466-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1466-5